Bioatlantis Holdings Ltd

BioAtlantis Holdings Limited operates as BioAtlantis, delivering stress mitigation technology worldwide through natural seaweed extract solutions. The company provides natural compounds extracted from renewable marine and terrestrial resources to reduce stress in crops, animals, and humans by strengthening natural defence systems. In agriculture, it aims to facilitate the transition to sustainable farming by reducing dependence on agrochemicals with products derived from natural resources. For animal health, its technology modulates the immune system and gastrointestinal microbiome using naturally-derived bioactives. In the human sector, BioAtlantis has developed targeted nutraceutical solutions to activate immunity and tackle metabolic diseases, with its first product, Digestica, expected to reach the market in 2023. The company is involved in several EU-funded research projects, including VASEACAD, BOOSTER, and CropPrime, highlighting its focus on research and development.